MedPath

Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine

Not Applicable
Completed
Conditions
Labor Pain
Interventions
Drug: Intrathecal morphine with fentanyl
Drug: Intrathecal morphine with bupivacaine
Registration Number
NCT02498171
Lead Sponsor
Makerere University
Brief Summary

This study is aimed at evaluating single short spinal technique as a form of labour analgesia in a setting where more expensive and labor intensive techniques are not feasible.The study will examine the safety and efficacy of two drug combinations (intrathecal morphine+fentanyl vs intrathecal morphine+bupivacaine) through a randomized control trial.

The investigators hypothesize that a single shot of either intrathecal morphine plus fentanyl or intrathecal morphine plus bupivacaine achieve analgesia and are safe in parturients experiencing normal labour.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
138
Inclusion Criteria
  • Parturients with singleton pregnancy
  • Emancipated minors
Exclusion Criteria
  • Those who declined.
  • Parturients with any identified complication of labour like preeclampsia, severe cardiac disease or previous operative delivery.
  • Sepsis or wound at site of spinal injection.
  • Allergy to any of the study drugs elicited from history.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intrathecal morphine with fentanylIntrathecal morphine with fentanylSingle shot of intrathecal morphine 100mcg mixed with 25mcg of fentanyl and filled up to make a 2ml solution. This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures.
Intrathecal morphine with bupivacaineIntrathecal morphine with bupivacaineSingle shot of intrathecal morphine 100mcg mixed with 2.5mg of spinal bupivacaine and filled up to make a 2ml solution.This would then be injected into the subarachnoid space through L2-3 or L3-4 following standard procedures.
Primary Outcome Measures
NameTimeMethod
Duration of analgesia10 hours

Monitoring the level of pain by the visual analogue scale to determine the total duration of analgesia in hours starting 5 min after drug administration

Secondary Outcome Measures
NameTimeMethod
APGAR score6 minutes

The effect of the drugs to the fetus shall be determined by proxy from the APGAR scores of the baby determined at 1 minute and then at 5 minutes. Poor APGAR scores are those equal or less than seven (7).

Maternal side effects (composite)34 hours

Maternal side effects including pruritis, urinary retention, high Bromage score, nausea and vomiting, abnormal blood pressure and pulse rate will be ascertained 24 hours after delivery.

© Copyright 2025. All Rights Reserved by MedPath